LAUSR

References 1 Brenner S, Wolf R, Ruocco V. Contact pemphigus: a subgroup of induced pemphigus. Int J Dermatol 1994; 33: 843–845. 2 Sebaratnam DF, Martin LK, Rubin AI, et al. Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus. Clin Exp Dermatol 2011; 36: 91–93. 3 Bauza A, Del Pozo LJ, Saus C, et al. Pemphigus-like lesions induced by imiquimod. Clin Exp Dermatol 2009; 34: e60–e62. 4 Lo Schiavo A, Sangiuliano S, Puca RV, et al. Contact pemphigus: a side-effect of imiquimod therapy. Int J Dermatol 2008; 47: 765–767. 5 Lin R, Ladd DJ Jr, Powell DJ, et al. Localized pemphigus foliaceus induced by topical imiquimod treatment. Arch Dermatol 2004; 140: 889–890. 6 Campagne G, Roca M, Martinez A. Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect. Eur J Obstet Gynecol Reprod Biol 2003; 109: 224–227. 7 Ruocco E, Baroni A, Rossiello L, et al. Imiquimod contact pemphigus: a comment. Eur J Obstet Gynecol Reprod Biol 2004; 115: 242–243. 8 Ruocco E, Aurilia A, Ruocco V. Precautions and suggestions for pemphigus patients. Dermatology 2001; 203: 201–207. 9 Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol 2000; 43: S6–S11. 10 Mashiah J, Brenner S. Possible mechanisms in the induction of pemphigus foliaceus by topical imiquimod treatment. Arch Dermatol 2005; 141: 908–909; author reply 909.